Robert Miller

Robert Miller

Chief Tech/Sci/R&D Officer at SCANCELL HOLDINGS PLC

Net worth: 42 310 $ as of 30/06/2026

Health Technology
Consumer Services
Health Services

Profile

Robert Matthew Miller is the founder of Fulcrum Pharma Plc, Artemida Pharma Ltd, and Scancell Holdings Plc.
He is currently the Medical Director at Scancell Holdings Plc, a Member at the American Society of Clinical Oncology, Inc., and a Member at the European Society for Medical Oncology.
Previously, he worked as the Director-Clinical Development at Protodigm Ltd., the Chief Medical Officer at Opsona Therapeutics Ltd., and the Chief Consultancy Physician at Aptiv Solutions, Inc. Dr. Miller holds a doctorate degree from the University of London and The Royal College of Surgeons of England.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
0.02%
01/06/2026 69,000 ( 0.02% ) 42 310 $ 30/06/2026

Robert Miller active positions

CompaniesPositionStart
SCANCELL HOLDINGS PLC Chief Tech/Sci/R&D Officer 17/11/2020
Corporate Officer/Principal -
Corporate Officer/Principal -
Artemida Pharma Ltd.
Founder -

Former positions of Robert Miller

CompaniesPositionEnd
Corporate Officer/Principal -
Chief Tech/Sci/R&D Officer -
Protodigm Ltd.
Corporate Officer/Principal -
Founder -
See the detail of Robert Miller's experience

Training of Robert Miller

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

82

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Consumer Services

Health Services

Health Services

Health Technology

Health Technology

Protodigm Ltd.

Consumer Services

Commercial Services

Artemida Pharma Ltd.